Zdrowie i gospodarka · 21/05/2020

FDA Renews Arthritis Advisory Committee for 2 Additional Years

The FDA has renewed the Arthritis Advisory Committee for an additional 2 years, with the new charter set to expire on April 5, 2024, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.